1. Home
  2. MLAB vs BXC Comparison

MLAB vs BXC Comparison

Compare MLAB & BXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLAB
  • BXC
  • Stock Information
  • Founded
  • MLAB 1982
  • BXC 2004
  • Country
  • MLAB United States
  • BXC United States
  • Employees
  • MLAB N/A
  • BXC N/A
  • Industry
  • MLAB Industrial Machinery/Components
  • BXC Wholesale Distributors
  • Sector
  • MLAB Industrials
  • BXC Consumer Discretionary
  • Exchange
  • MLAB Nasdaq
  • BXC Nasdaq
  • Market Cap
  • MLAB 680.0M
  • BXC 663.8M
  • IPO Year
  • MLAB N/A
  • BXC 2004
  • Fundamental
  • Price
  • MLAB $112.01
  • BXC $71.94
  • Analyst Decision
  • MLAB Hold
  • BXC Strong Buy
  • Analyst Count
  • MLAB 2
  • BXC 5
  • Target Price
  • MLAB $140.00
  • BXC $125.20
  • AVG Volume (30 Days)
  • MLAB 58.3K
  • BXC 107.0K
  • Earning Date
  • MLAB 05-30-2025
  • BXC 04-29-2025
  • Dividend Yield
  • MLAB 0.57%
  • BXC N/A
  • EPS Growth
  • MLAB N/A
  • BXC 14.84
  • EPS
  • MLAB N/A
  • BXC 6.19
  • Revenue
  • MLAB $237,747,000.00
  • BXC $2,952,532,000.00
  • Revenue This Year
  • MLAB $13.48
  • BXC $4.52
  • Revenue Next Year
  • MLAB $4.74
  • BXC $5.77
  • P/E Ratio
  • MLAB N/A
  • BXC $11.62
  • Revenue Growth
  • MLAB 11.68
  • BXC N/A
  • 52 Week Low
  • MLAB $83.68
  • BXC $67.42
  • 52 Week High
  • MLAB $155.12
  • BXC $134.79
  • Technical
  • Relative Strength Index (RSI)
  • MLAB 42.12
  • BXC 41.60
  • Support Level
  • MLAB $109.95
  • BXC $68.70
  • Resistance Level
  • MLAB $117.85
  • BXC $72.91
  • Average True Range (ATR)
  • MLAB 8.18
  • BXC 4.21
  • MACD
  • MLAB 0.63
  • BXC 0.19
  • Stochastic Oscillator
  • MLAB 59.94
  • BXC 42.09

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About BXC Bluelinx Holdings Inc.

BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.

Share on Social Networks: